Media can register now for the Advanced Breast Cancer Eighth International Consensus Conference (ABC 8), which takes place in Lisbon, Portugal, on Thursday 6 to Saturday 8 November 2025. Registration for bona fide journalists is free.
Around 1,500 participants from over 100 countries around the world will join this major international breast cancer conference, including health professionals and patient advocates. Sessions and presentations will include:
- ABC Global Decade report 2015-2025: how far have we come?
- Managing brain metastases (cancer that has spread to the brain)
- Accessibility and affordability: has the gap widened? Could AI and telemedicine help?
- Long-term responders: can we talk about a cure?
- Palliative care.
Media registration
To register for ABC 8, go to:
https://www.abc-lisbon.org/en/media/Media-registration/1-427-1- where you can access the registration form for journalists.
Registration is free to bona fide representatives of print, electronic and broadcast media. A copy of a valid, recognised press card and/or of a commissioning letter on headed paper from a recognised news organisation or publication must be submitted with your application. Representatives of advertising, marketing and public relations companies are not eligible for free media registration.
For further information about media registrations, contact:
Helder Carvalho, email: helder.carvalho@abreu.pt
Despite major advances in the treatment of early breast cancer in the past decades, patients with advanced breast cancer face a poor prognosis, and are under-served and largely forgotten [1]. There are no reliable figures for the numbers of women and men living with advanced breast cancer. However, there are over two million new cases of breast cancer a year in the world and 0.6 million deaths. About 5-10% of cases are either locally advanced or have spread to other parts of the body at diagnosis, and these figures can reach 80% in developing countries. About a third of all early breast cancer cases will become metastatic even with the best care, and the average overall survival for these patients is between three and five years.
At the end of the ABC 8 conference, a group of world-renowned breast cancer experts will agree on a new set of guidelines for the best treatment of ABC patients, and these will be published subsequently in the peer-reviewed journal
The Breast (Elsevier). The guidelines are based on the most up-to-date evidence and can be used to guide treatment decision-making in many different health care settings globally, with the necessary adaptations due to different access to care. These guidelines constitute the international guidelines for the management of this disease and are widely used all over the world. [2]
This year marks the end of the first decade of the
ABC Global Alliance’s work, guided by the ten goals of the ABC Global Charter 2015-2025. A comprehensive Decade Report 2015-2025 will be launched and discussed during the ABC 8 conference. The findings of this report are the basis for the new ABC Global Charter 2025-2035 – a new set of ten goals that unite the ABC community in the fight for improving the lives of those living with advanced/metastatic breast cancer worldwide.
The organisers of ABC 8 welcome the interest of the media in breast cancer issues and are happy to provide full assistance to journalists who wish to report on the conference or use the
ABC website as a resource in their coverage. All the conference sessions will be open to journalists and experts will be available for interview.
[1] Advanced breast cancer is defined as cancer that has spread beyond the site of the first (primary) tumour to other sites either within the same breast such as the skin, chest wall and some lymph nodes (locally advanced) or other parts of the body (metastatic cancer).